NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Facilities

IAMA is developing IAMA-6 for potentially treating drug-resistant epilepsies and rare syndromic forms of autism. (Credit: valelopardo from Pixabay)

IAMA Therapeutics Announces Multi-Phase, Strategic Provider....
03 Oct 23

ABB India to automate biopharmaceutical facilities....
21 Aug 23

Teladoc, Microsoft expand collaboration to address....
19 Jul 23

LINDT GOLD BUNNY AND JENNA DEWAN....
21 Mar 23

DEALS

Intercept is focused on treatments for rare and serious liver diseases. (Credit: Roberto Sorin on Unsplash)

Italy’s Alfasigma to purchase Intercept Pharmaceuticals....
27 Sep 23

Biogen Completes Acquisition of Reata Pharmaceuticals
27 Sep 23

Glenmark to divest majority stake in....
22 Sep 23

Novo, Gurnet Point wrap up $462m....
22 Sep 23

CONTRACTS

SGC, HitGen collaborate on DEL technology. (Credit: Michal Jarmoluk from Pixabay)

SGC, HitGen collaborate on DEL technology....
29 Sep 23

Menarini Asia-Pacific, Astellas partner to commercialise....
13 Sep 23

Broad Institute enters into new research....
07 Sep 23

US government announces $1.4bn funding for....
23 Aug 23

Company Insight